| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a8532789c967d0dcfa2f3d744f53f2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66b9878e7327b5fb1ad022d2504014c4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1275 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
1994-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_684900890e9572911821e6466a9ae735 |
| publicationDate |
1994-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9420145-A1 |
| titleOfInvention |
Use of low density lipoprotein with cytotoxic substances |
| abstract |
A cytotoxic agent, when formulated in a low density lipoprotein, is useful for treating cancers, particularly leukaemias and lymphomas, since the lipoprotein enhances the activity of the cytotoxic agent. It is particularly useful for cancers which are resistant to the cytotoxic drug when administered without LDL and for the administration of drugs which are insoluble in non-toxic solvents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11332494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801874-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11559486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017187343-A3 |
| priorityDate |
1993-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |